This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Notes of a Wart Watcher

Karl R. Beutner, MD, PhD

Arch Dermatol. 1990;126(11):1432-1435.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Until a modern equivalent of spunk water is available, what are reasonable expectations of wart therapy? What is the oncogenic potential of human papillomavirus (HPV) and what should we tell patients to adequately inform them without terrorizing them? Despite a great increase in the number of publications and an ever growing body of information about HPV infection, HPV molecular biology, and virology, there remains a paucity of clinically applicable knowledge about this common infection.

This brief overview summarizes the current knowledge relevant to common clinical issues in an attempt to bridge the gap between information and knowledge.

It is clear that HPV produces a latent infection. Human papillomavirus(es) is a group (at least 60 types) of epithelialtrophic viruses that result in latent infection and a spectrum of clinical disease.^1,2 The latent nature of the infection is demonstrated by at least four observations.

First, subjects with no clinical history of HPV infection have antibodies to HPV.³ Second, HPV DNA is present in normal mucosa from patients with laryngeal papillomatosis." Third, HPV DNA is present in normal tissue obtained 0.5 to 1.0 cm beyond surgical margins in women with vulvar warts.⁵ . . . [Full Text PDF of this Article]

Author Affiliations
1516 Napa St Vallejo, CA 94590

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?